Clinical Trials in Chaoyang, China
1 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Boehringer Ingelheim11,000 enrolled399 locationsNCT06531824
Recruiting
Not Applicable
Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial
Oral Tongue Squamous Cell Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University190 enrolled28 locationsNCT07402525
Recruiting
Phase 1
A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma
Advanced Solid TumorNSCLCLymphoma+1 more
Betta Pharmaceuticals Co., Ltd.110 enrolled4 locationsNCT05341557
Recruiting
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Liver CancerPancreatic CancerGastric Cancer+8 more
Zhujiang Hospital12,000 enrolled50 locationsNCT05638269
Recruiting
The Chinese Familial Alzheimer's Network
Alzheimer DiseaseFamilial Alzheimer Disease (FAD)
Capital Medical University40,000 enrolled65 locationsNCT03657732
Recruiting
China Cognition and Aging Study
Mild Cognitive Impairment (MCI)Alzheimer Disease, Late OnsetFamilial Alzheimer Disease (FAD)+3 more
Capital Medical University100,000 enrolled65 locationsNCT03653156